EFFECTS OF THE ANTITUMOR ANTIBIOTIC MITHRAMYCIN ON THE STRUCTURE OF REPETITIVE DNA REGIONS ADJACENT TO ITS GC-RICH BINDING-SITE

被引:22
作者
CONS, BMG [1 ]
FOX, KR [1 ]
机构
[1] UNIV SOUTHAMPTON,DEPT PHYSIOL & PHARMACOL,BASSETT CRESCENT E,SOUTHAMPTON SO9 3TU,HANTS,ENGLAND
基金
英国惠康基金;
关键词
D O I
10.1021/bi00239a033
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Regions of A(n).T(n), (GA)n.(TC)n, and (GT)n.(AC), have been cloned into the SmaI (CCC/GGG) site of plasmid pUC19. HindIII-EcoRI restriction fragments containing these inserts have been used as substrates for footprinting experiments using DNase I, DNase II, and micrococcal nuclease as probes. These present good mithramycin binding sites (GGG) flanking repetitive regions to which the drug does not bind. In each case, mithramycin footprints are observed at the CCC/GGG sites, which are not affected by the nature of the surrounding sequences. Some weaker binding is detected at TCGA and ACCA sites and at regions of alternating GA. No binding is found to regions of alternating GT. A(n).T(n) inserts (n = 23 or 69) are normally resistant to cleavage by all these probes; in the presence of mithramycin, a dramatic increase in DNase I cleavage is observed throughout the entire insert and is indicative of an alteration in DNA structure. Similar changes are seen with DNase II and micrococcal nuclease. These changes cannot be explained by invoking changes in the ratio of free substrate to cleavage agent. In contrast, cleavage of (GA)n.(CT)n and (GT)n.(AC)n inserts is not affected by drug binding. The results are consistent with a model in which mithramycin causes dramatic changes in the width of the DNA minor groove, generating a structure which has some properties of A-DNA, and suggest that this can be propagated into surrounding DNA regions in a sequence-dependent manner. The structural alterations with A(n).T(n) are highly cooperative and can be transmitted over at least three turns of the DNA helix.
引用
收藏
页码:6314 / 6321
页数:8
相关论文
共 44 条
[1]   HETERONOMOUS DNA [J].
ARNOTT, S ;
CHANDRASEKARAN, R ;
HALL, IH ;
PUIGJANER, LC .
NUCLEIC ACIDS RESEARCH, 1983, 11 (12) :4141-4155
[2]   THE PROPELLER DNA CONFORMATION OF POLY(DA).POLY(DT) [J].
AYMAMI, J ;
COLL, M ;
FREDERICK, CA ;
WANG, AHJ ;
RICH, A .
NUCLEIC ACIDS RESEARCH, 1989, 17 (08) :3229-3245
[3]   NMR-STUDIES OF THE INTERACTION OF CHROMOMYCIN-A3 WITH SMALL DNA DUPLEXES - BINDING TO GC-CONTAINING SEQUENCES [J].
BANVILLE, DL ;
KENIRY, MA ;
KAM, M ;
SHAFER, RH .
BIOCHEMISTRY, 1990, 29 (27) :6521-6534
[4]   NMR INVESTIGATION OF MITHRAMYCIN-A BINDING TO D(ATGCAT)2 - A COMPARATIVE-STUDY WITH CHROMOMYCIN-A3 [J].
BANVILLE, DL ;
KENIRY, MA ;
SHAFER, RH .
BIOCHEMISTRY, 1990, 29 (39) :9294-9304
[5]   INTERACTION OF RNA POLYMERASE INHIBITOR CHROMOMYCIN WITH DNA [J].
BEHR, W ;
HONIKEL, K ;
HARTMANN, G .
EUROPEAN JOURNAL OF BIOCHEMISTRY, 1969, 9 (01) :82-&
[6]   EQUILIBRIUM STUDIES OF ETHIDIUM-POLYNUCLEOTIDE INTERACTIONS [J].
BRESLOFF, JL ;
CROTHERS, DM .
BIOCHEMISTRY, 1981, 20 (12) :3547-3553
[7]   INTERACTION OF ACTINOMYCIN WITH DNA - REQUIREMENT FOR 2-AMINO GROUP OF PURINES [J].
CERAMI, A ;
REICH, E ;
WARD, DC ;
GOLDBERG, IH .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1967, 57 (04) :1036-&
[8]   INTERACTION OF MITHRAMYCIN WITH METAL-IONS AND DNA [J].
CONS, BMG ;
FOX, KR .
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1989, 160 (02) :517-524
[9]  
CONS BMG, 1990, ANTI-CANCER DRUG DES, V5, P93
[10]   THE GC-SELECTIVE LIGAND MITHRAMYCIN ALTERS THE STRUCTURE OF (AT)N SEQUENCES FLANKING ITS BINDING-SITES [J].
CONS, BMG ;
FOX, KR .
FEBS LETTERS, 1990, 264 (01) :100-104